
Jupiter Neurosciences Launches Nugevia™ Longevity Supplement Line to Drive Revenue and Address Growing Market
Jupiter Neurosciences Inc. has launched its Nugevia™ direct-to-consumer longevity supplement line, leveraging its JOTROL™ resveratrol formulation to generate immediate revenue while developing pharmaceutical treatments, targeting a market projected to reach $314 billion by 2030.
Read full story
























